Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension

Stroke

Volumn 39, Issue 2, 2008, Pages 349-354

  Dai, Weiying ^a   Lopez, Oscar L ^a,e   Carmichael, Owen T ^b   Becker, James T ^a   Kuller, Lewis H ^a   Gach, H Michael ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEVADA CANCER INSTITUTE   (United States)

^d UNIVERSITY OF NEVADA   (United States)

^e NONE   (United States)

Author keywords

CASL; Cerebral blood flow; Cognition; Hypertension; MRI

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CINGULATE GYRUS; CLUSTER ANALYSIS; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DISEASE PREDISPOSITION; FEMALE; GERIATRIC PATIENT; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; STROKE; BRAIN CIRCULATION; BRAIN CORTEX; COGNITIVE DEFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIN LABELING; VASCULARIZATION;

AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION; COGNITION DISORDERS; FEMALE; GLOBUS PALLIDUS; GYRUS CINGULI; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; PUTAMEN; SPIN LABELS;

EID: 39349089972     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.495457     Document Type: Article

References (39)

1. Wolf-Maier K, Cooper RS, Banegas J, Giampaoli S, Hense HW, Joffres M, Kastarinen MPN, Primatesta P. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2362-2369.
2. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31:780-786.
3. Kivipelto M, Helkala E-L, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment. Neurology. 2001;56:1683-1689.
4. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik R. The association between mid-life blood pressure levels and late life cognitive function: the Honolulu - Asia Aging Study. JAMA. 1995;274:1846-1851.
5. Struijs J, van Genugten LL, Evers SMAA, Ament AJHA, Baan CA, van den Bos GAM. Modeling the future burden of stroke in The Netherlands: impact of aging, smoking, and hypertension. Stroke. 2005;36:1648-1655.
6. Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke. 1993;24(suppl 12):I22-I32.
7. van Dijk EJ, Breteler MB, Schmidt R, Berger K, Nilsson L-G, Oudkerek M, Pajak A, Sans S, de Ridder MCD. The association between blood pressure, hypertension, and cerebral white matter lesions. The Cardiovascular Determinants of Dementia Study. Hypertension. 2004;44:625-630.
8. Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Disord. 2001;12:251-256.
9. Hebert LE, Scherr PA, Bennett DA, Bienias JL, Wilson RS, Morris MC, Evans DA. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004;62:2021-2024.
10. Qiu C, Winblad B, Fastbom J, Fratiglioni L. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology. 2003;61:656-660.
11. Kivipelto M, Helkala E-L, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-1451.
12. Skoog I, Lernfeldt B, Landahl S. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
13. Jennings JR, Muldoon MF, Ryan CM, Mintun MA, Meltzer C, Townsend D, Sutton-Tyrel K, Shapiro AP, Manuck SB. Cerebral blood flow in hypertensive patients: an initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks. Hypertension. 1998;31:1216-1222.
14. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, van der Veen FM, Meltzer CC. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology. 2005;64:1358-1365.
15. Fujishima S, Imaizumi T, Abe I, Takeshita A, Fujishima M. Effects of intra-arterial infusion of insulin on forearm vasoreactivity in hypertensive humans. Hypertens Res. 1995;18:327-333.
16. Mentis MJ, Salerno J, Horwitz B, Grady CL, Schapiro MB, Murphy DC, Rapoport SI. Reduction of functional neuronal connectivity in long-term treated hypertension. Stroke. 1994;25:601-607.
17. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007;39:1766-1773.
18. Gianaros PJ, Derbyshire SW, May JC, Siegle GJ, Gamalo MA, Jennings JR. Anterior cingulate activity correlates with blood pressure during stress. Psychophysiology. 2005;42:627-636.
19. Gianaros PJ, Greer PJ, Ryan CM, Jennings JR. Higher blood pressure predicts lower regional grey matter volume: consequences on short-term information processing. Neuroimage. 2006;31:754-765.
20. Korf ESC, White LR, Scheltens P, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension. 2004;44:29-34.
21. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239-259.
22. Talagala SL, Noll DC. Functional MRI using steady state arterial water labeling. Magn Reson Med. 1998;39:179-183.
23. Gach HM, Dai W. Simple model of double adiabatic inversion (DAI) efficiency. Magn Redon Med. 2004;52:941-946.
24. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol. 2000;47:93-100.
25. Johnson NA, Jahng G-H, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005;234:851-859.
26. Brown GG, Clark CM, Liu TT. Measurement of cerebral perfusion with arterial spin labeling: part 2. Applications. J Int Neuropsychol Soc. 2007;13:1-13.
27. Liu TT, Brown GG. Measurement of cerebral perfusion with arterial spin labeling: part I. Methods. J Int Neuropsychol Soc. 2007;13:1-9.
28. Lopez OL, Kuller LH, Becker JT, Dulberg C, DeKosky S, Sweet R, Gach M. Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study. Arch Neurol. 2007;64:416-421.
29. Lezak M. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press; 1995.
30. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48:314-318.
31. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluations of dementia in the Cardiovascular Health Cognition study. Neuroepidemiology. 2003;22:1-12.
32. den Heijer T, Launer LJ, van Dijk EJ, Vermeer SE, Hofman A, Koudstaal PJ, Breteler MMB. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology. 2005;64:263-267.
33. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingular cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85-94.
34. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology. 2005;64:102-107.
35. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. NeuroReport. 2002;13:1939-1943.
36. Karas GB, Scheltens P, Rombouts SARB, Visser PJ, van Schijndel RA, Fox NC, Barkhof F. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage. 2004;23:708-716.
37. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, MB, Savitcheva I, Huang G, Estrada S. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compond-B. Ann Neurol. 2004;55:306-319.
38. Snowdon DA, Grainer LH, Mortimer JA, Riley KP, Grainer PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun study. JAMA. 1997;277:813-817.
39. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS, Honolulu - Asia Aging Study. Neurobiol Aging. 2000;21:57-62.